Product
Pralidoxime
1 clinical trial
1 indication
Indication
Organophosphorus PoisoningClinical trial
Outcome of OPC Poisoning Patients Between Two Treatment Groups One With Atropine Plus Pralidoxime and Other With Only AtropineStatus: Recruiting, Estimated PCD: 2024-10-01